Evidence-Based Complementary and Alternative Medicine

Evidence-Based Complementary and Alternative Medicine / 2014 / Article
Special Issue

Translational Research in Complementary and Alternative Medicine 2014

View this Special Issue

Research Article | Open Access

Volume 2014 |Article ID 204797 | 7 pages | https://doi.org/10.1155/2014/204797

Diarylheptanoids from Alpinia officinarum Cause Distinct but Overlapping Effects on the Translatome of B Lymphoblastoid Cells

Academic Editor: Wei Jia
Received16 May 2014
Revised25 Jul 2014
Accepted25 Jul 2014
Published31 Aug 2014


Diarylheptanoids (AO-0001, AO-0002, and AO-0003) isolated from Alpinia officinarum inhibit proinflammatory mediators and exhibit cytotoxic and antiviral activity. However, the precise mechanisms of action of these diarylheptanoids are unknown as are their effects on expression of specific genes. Here, we used a translatome analysis to investigate the mechanisms and modes of action of these three diarylheptanoids. Polysome-associated messenger RNAs (mRNAs) were prepared from diarylheptanoids-treated and control cells from a human B lymphoblastoid cell line; these mRNA samples were then used for microarray analysis. Microarray Data Analysis Tool version 3.2 was used to analyze the microarray data analysis; this software uses pathway information of the WikiPathways for gene ontology analysis. Each of the diarylheptanoids caused upregulation or downregulation of the same 37 and 286 genes, respectively. Among the 37 upregulated genes, 16 were related to mRNA processing based on the WikiPathways analysis. Our findings provided new insights into the mode of action of diarylheptanoids from A. officinarum.

1. Introduction

Alpinia officinarum belongs to the family Zingiberaceae and is known as lesser galangal. A. officinarum rhizomes have been used in many Asian cuisines and as traditional medicine; these rhizomes have been used as antiemetics, stomachics, and analgesics in Asia since ancient times. In a series of studies on bioactive compounds from natural sources, we found that a methanol extract from the rhizome of A. officinarum is effective in inhibiting 12-O-tetradecanoylphorbol-13-acetate- (TPA-) induced tumor promotion in skin of mice [1]. Diarylheptanoids isolated from A. officinarum have many reported effects; they inhibit the melanogenesis caused by B16 melanoma cells [2]; induce apoptosis, S-phase arrest, and differentiation of human neuroblastoma cells [3]; exhibit cytotoxic activity [4]; suppress inducible nitric oxide synthase expression [5]; inhibit biosynthesis of prostaglandin and leukotrienes [6, 7]; and inhibit proinflammatory mediators [8]. Additionally, diarylheptanoids reportedly have antiviral activity against influenza virus [9, 10], respiratory syncytial virus, poliovirus, measles virus, herpes simplex virus, and type 1 poliovirus [11, 12]. However, the precise mechanisms of action of these diarylheptanoids are undefined as are any effects they have on the expression of specific genes.

Over the last 10 years, translatome analyses of eukaryotic cells or tissues have been increasingly used by researchers. The polysome microarray approach, which was originally reported by Zong et al., is the most commonly used method for translatome analysis [13]. With this approach, mRNAs associated with several ribosomes (usually 3) are separated from mRNAs associated with fewer ribosomes; these polysome-associated mRNAs are then used to label probes on microarrays [14]. As genetic information transforms from DNA to protein, the cellular abundance of proteins is predominantly controlled at the level of translation [15]; observed correlations between mRNA levels and respective protein levels are low [16]. Analysis of the translatome, an intermediate level between the transcriptome and the proteome represented by polysome-associated mRNAs, has provided substantial and somewhat surprising new information [17].

In this study, we used this microarray-based approach to comprehensively identify the polysome-associated mRNAs in a human B lymphoblastoid cell line (BJAB) and to examine changes to this mRNA profile caused by each of the three A. officinarum diarylheptanoids.

2. Materials and Methods

2.1. Chemicals

Chemicals were purchased from Wako Pure Chemical Industries, Ltd., Osaka, Japan. AO-0001: (5R)-7-(4′′-hydroxy-3′′-methoxyphenyl)-5-methoxy-1-phenyl-3-heptanone, AO-0002: (5R)-5-hydroxy-7-(4′′-hydroxy-3′′-methoxyphenyl)-1-phenyl-3-heptanone, and AO-0003 : 7-(4′′-hydroxy-3′′-methxoyphenyl)-1-phenyl-4E-hepten-3-one (Figure 1) were isolated from the rhizome of A. officinarum as described previously [4]; each was stored as 40 mM stock solution in 100% dimethyl sulfoxide (DMSO) (final concentration of DMSO 0.1%).

2.2. Cell Culture

BJAB cells were grown in Roswell Park Memorial Institute (RPMI) 1640 medium (Sigma), 10% fetal bovine serum (Sigma), 5 μg/mL amphotericin B (Bristol-Myers), and 10 μg/mL gentamicin (Sigma). The cells were maintained at 37°C with 5% CO2 in a humid environment [18]. Proliferation of the BJAB B-lymphoblastoid cell line is rapidly and almost completely suppressed by picomolar concentrations of the immunosuppressive macrolide rapamycin [19]. This hypersensitivity to rapamycin of BJAB cells might indicate that the canonical translation system in BJAB is highly dependent on mTOR (mammalian target of rapamycin) and is highly activated. Thus, we used BJAB cells.

2.3. Cellular Fractionation and RNA Preparation

Polysome analysis was performed as described previously [18] with slight modifications. Briefly, 40 mL of exponentially growing BJAB cells (0.5 × 106 cells/mL) was untreated or was treated with DMSO-only, 40 μM AO-0001, 40 μM AO-0002, or 40 μM AO-0003 for 3 hours. The concentration of each diarylheptanoid used for treatment was determined based on previous findings [25]. To prepare cytoplasmic extract for ribosomal fractionation, cells were washed with ice-cold RPMI 1640 medium containing 0.1 mg/mL cycloheximide and collected by centrifugation; each resulting pellet was homogenized with a Teflon pestle in an Eppendorf tube in ice-cold 0.375 mL of low salt buffer (LSB) (0.1 M NaCl, 3 mM MgCl2, 20 mM Tris-HCl [pH 7.6], and 1 mM dithiothreitol). Next, 100 μL of lysis buffer (LSB with 0.2 M sucrose, 1.2% Triton N-101), 15 μL of 5 M NaCl, and 50 μL of 10 mg/mL heparin-Na in LSB were added to each homogenate; each mixture was centrifuged at 10,000 ×g for 5 min to clear the resultant supernatant of nuclei, mitochondria, and debris. Lysate (0.4 mL) was layered over a 4.5 mL linear sucrose gradient solution (0.5–1.5 M in LSB, prepared by Gradient Master 107, Biocomp) in a 5 mL tube and centrifuged at 47,000 rpm for 70 minutes at 4°C in Hitachi RPS 55ST rotor. Each gradient was fractioned at a rate of 0.5 mL per minute by upward displacement via a Piston Gradient Fractionator (Biocomp), which was equipped with an absorbance monitor (BioLogic DuoFlow and BioLogic Optics Module II OM-1). Resulting profiles of absorbance at 254 nm are shown in Figure 2. Each fraction was stored at −30°C until use for total RNA extractions [18].

2.4. RNA Preparation for CodeLink Human Whole Genome Bioarray Analysis

The microarray analysis was performed as a trust analysis service at Filgen Incorporation (Nagoya, Japan). The Agilent Bioanalyzer 2100 RNA Nano LabChip (Agilent Technologies) analysis system was used to assess the RNA quality of each experimental sample. Under standard conditions, processing of RNAs used with the CodeLink Human Whole Genome Bioarray (Applied Microarrays, Inc.) was in accordance with methods described in the manufacturer’s instructions, as subsequently detailed. MessageAmp II-Biotin Enhanced Kits (Ambion) were used to synthesize 10 μg of biotin-labeled RNA from each experimental sample.

2.5. Microarray Hybridization, Scanning, Normalization, and Annotation

Hybridization was carried out according the instructions supplies with the CodeLink Controls and Buffer Kit (Applied Microarrays, Inc.). For each experimental sample, 10 μg of biotin-labeled material was the nominal amount of material used on the CodeLink Bioarrays. The arrays and labeled material were incubated together at a constant temperature of 37°C overnight. GenePix 4400A (Molecular Devices, Inc.) was used to scan each labeled array. CodeLink Expression Analysis v5.0 (Applied Microarrays, Inc.) software was used for the data analysis. Net intensity was calculated by withdrawing surrounding background of the spot from row intensity. Normalization is performed by adjusting the median of all the read microarray data with a fixed value. Microarray Data Analysis Tool version 3.2 (Filgen, Inc.) was used as described in the manufacturer’s instruction for all subsequent data analysis. This software uses pathway information and data from either GenMAPP (http://www.genmapp.org/) or WikiPathways. We used data from the WikiPathways database because it is an open, collaborative platform dedicated to curating biological pathways (http://www.wikipathways.org/index.php/WikiPathways).

3. Results

3.1. Translatome Analysis of Diarylheptanoid-Treated BJAB Cells

To catalogue ribosome loading onto BJAB mRNAs in the presence or absence of diarylheptanoids isolated from A. officinarum (Figure 1), we generated polysomal profiles of BJAB cells under each of four conditions (Figure 2). Treatment with AO-0001 or AO-0003 decreased ribosome loading onto mRNAs in BJAB cells. We quantified the fraction of all mRNAs that bound more than 2 ribosomes; we then labeled these polysome-associated mRNAs with biotin and used the labeled mRNAs to label CodeLink Bioarrays. After normalizing net intensity for each probe, sample versus control ratios were calculated for each probe. Probes indicating more than 2-fold upregulation (ratio 2) or 2-fold downregulation (ratio 0.5) of the respective transcript or gene are listed in Table 1. The microarray analysis indicated that each of AO-0001, AO-0002, and AO-0003 altered (downregulated or upregulated) polysomal loading of more than 3,000 transcripts/genes (Table 1). Treatment versus control net intensity values were plotted for any transcript that exhibited a normalized net intensity value greater than 40 and that was upregulated (ratio 2) or downregulated (ratio 0.5) (Figure 3(a)). Total mRNA isolated from monosome fractions of AO-0003 treated BJAB cells was also used for DNA microarray analysis; these data were processed and are plotted in Figure 3(a). Each of AO-0001, AO-0002, and AO-0003 caused downregulation of 37 genes and upregulation of 286 genes in the treatment versus control normalized net intensity values which were plotted for each of these transcripts. The plots of AO-0001-affected transcripts and AO-0003-affected transcripts were very similar. Each of AO-0001 and AO-0002 caused downregulation of multiple genes encoding proinflammatory mediators [8, 20]; AO-0001 downregulated interleukin 8 (ratio of net intensity; 0.409), interleukin 18 (IL-18) (0.489), macrophage inflammatory protein-1 (0.241), and epidermal growth factor receptor (0.439); AO-0002 downregulated IL-18 (0.487) and macrophage inflammatory protein-1 (0.330). Each of AO-0001, AO-0002, and AO-0003 caused downregulation of the transcription factor notch-1 with the following net intensities, 0.244, 0.450, and 0.418, respectively.

AO-0001AO-0002AO-0003Common Gene

Downregulated (ratio 0.5)965 634950 663900 58537
Upregulated (ratio 2)1308 9941960 13491574 1222286
Total altered2273 16282910 20122474 1807323

Total of 54359 probes were used.
3.2. WikiPathways Analysis

The Microarray Data Analysis Tool version 3.2 (Filgen, Inc.) was used for follow-up pathway analysis. This software uses pathway information that can be taken from either of GenMAPP (http://www.genmapp.org/) or WikiPathways. We chose to use the WikiPathways (http://www.wikipathways.org/index.php/WikiPathways) because it is publically available. AO-0001, AO-0002, and AO-0003 altered 7, 4, and 10 (resp.) of the pathways curated in WikiPathways database (Table 2). AO-0001 treatment of BJAB cells altered regulation of diurnally regulated genes with circadian orthologs. AO-0002 altered regulation of genes involved in proteasome degradation. AO-0003 altered regulation of genes involved in calcium regulation in the cardiac cell, cell cycle, mitogen-activated protein kinases (MAPK) signaling, or some combination thereof.

WikiPathways Total gene
Pathway name scoreAltered gene number scoreAltered gene number scoreAltered gene number

Alanine and aspartate metabolism WP106 41117122.7343.335
Apoptosis WP254 4118479−2.182−2.452
Calcium regulation in the cardiac cell WP536 41204145−2.198
Cell cycle WP179 45137722.9316
Diurnally regulated genes with circadian orthologs WP410 41104422.529
DNA replication WP466 41036*1383.951113
Glycolysis and gluconeogenesis WP534 41077453.291114
GPCRs, class A rhodopsin-like WP455 41121*2227−3.407−2.67 13−3.0511
MAPK signaling pathway WP382 41048*3153−2.109
mRNA processing WP411 45374*41107.40345.54 319.8045
Proteasome degradation WP183 45274523.09 13
Translation factors WP107 41026423.02 113.0511

WikiPathways transcripts with a value < 0.5 are listed.
*1DNA: deoxyribonucleic acids
*2GPCRs: G protein-coupled receptors
*3MAPK: mitogen-activated protein kinases
*4The following 16 transcripts were each upregulated after treatment with each diarylheptanoid (AO-0001, AO-0002, or AO-0003). CSTF1: cleavage stimulation factor, 3′ pre-RNA, subunit 1, 50 kDa; CSTF3: cleavage stimulation factor, 3′ pre-RNA, subunit 3, 77 kDa; DDX1: DEAD (Asp-Glu-Ala-Asp) box helicase 1; FUS: fused in sarcoma; HNRNPAB: heterogeneous nuclear ribonucleoprotein A/B; HNRNPC: heterogeneous nuclear ribonucleoprotein C (C1/C2); HNRNPK: heterogeneous nuclear ribonucleoprotein K; NONO: non-POU domain containing, octamer-binding; PTBP1: polypyrimidine tract binding protein 1; PRPF40A: PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae); PRPF6: PRP6 pre-mRNA processing factor 6 homolog (S. cerevisiae); SRSF7: serine/arginine-rich splicing factor 7; SNRNP70: small nuclear ribonucleoprotein 70 kDa (U1); SF3A3: splicing factor 3a, subunit 3, 60 kDa; SF3B2: splicing factor 3b, subunit 2, 145 kDa; U2AF2: U2 small nuclear RNA auxiliary factor 2.

Notably, each diarylheptanoid altered class A rhodopsin-like GPCRs and the mRNA processing pathway (Table 2). Based on the WikiPathways analysis, AO-0001, AO-0002, and AO-0003 affected 35, 34, and 46 (resp.) mRNA processing-related genes; moreover, 16 of these transcripts were upregulated by all three diarylheptanoids.

3.3. Features of 5′ UTRs of Transcripts Regulated by Each Diarylheptanoid, AO-0001, AO-0002, and AO-0003

Different types of cis-acting elements encoded in mRNA 5′ untranslated region (5′ UTR) sequences can mediate regulation of translational initiation; such elements include (1) secondary structure that can block a scanning ribosome and thereby inhibit recognition of an AUG initiation codon, (2) IRESs that stimulate cap-independent translation, (3) protein binding sites that either repress or promote translation in response via transacting factors, and (4) upstream AUG codons, in some cases, associated with upstream open reading frames (uORFs) [21]. We analyzed in-frame uORF and terminator codons of the 5′UTR of 329 transcripts that were each regulated by each of the diarylheptanoids, AO-0001, AO-0002, and AO-0003 (Table 3). Of these transcripts, 49 (14%) contained a uORF, and uORFs were present in both downregulated and upregulated transcripts. Additionally, 53% of the upregulated transcripts each contained an in-frame terminator codons.

Upstream open reading frameIn-frame stop codonOther features
Number of transcripts% of totalNumber of transcripts% of totalNumber of transcripts% of total

Downregulated (Ratio 0.5)514%1643%1643%
Upregulated (Ratio 2)4114%15653%9533%

Interactions between RNA binding proteins and RNA elements control mRNA translation [22]. To date, at least 25 cellular IRES-containing mRNAs have been identified [2328]. Among these cellular IRES-containing mRNAs, AO-0001 upregulated the mRNA encoding the insulin receptor (ratio of net intensity: 2.582), and AO-0002 downregulated the human inhibitor of apoptosis 2 protein transcript (0.448).

4. Discussion

Recently, Tebaldi et al. showed that the analysis of the translatome, an intermediate between the transcriptome and the proteome comprising polysome-associated mRNAs, can provide substantial and somewhat surprising information [17]. Translatome analyses can identify gene ontology (GO) terms within gene sets that represent the transcriptome, translatome, or proteome and then compare between sets with regard to GO term; this approach parses information about cellular components, molecular functions, and biological processes subject to differential regulation at different levels of gene expression [29]. Translatome analysis renders detection of “stress response” and “translation” related genes compared with transcriptome analysis. In this study, 16 transcripts that relate to mRNA processing were identified from the WikiPathways database (Table 2).

Each of AO-0001, AO-0002, and AO-0003 has anti-inflammatory effects and inhibits tumor progression [1, 2]. The dose (μmol/ear) of 50% inhibitory dose of TPA-induced inflammation was AO-0001 AO-0002 AO-0003. Notably, the number of downregulated inflammatory related transcripts was greatest with AO-0001; it was fewer with AO-0002 and fewest with AO-0003. Future examination of the relationships between the anti-inflammatory effect of each diarylheptanoid and the resulting corresponding levels of IL-8, IL-18, macrophage inflammatory protein-1 , notch-1, and epidermal growth factor in vivo is important.

AO-0001 has lower cytotoxic effects on IMR-32 cells than does AO-0003 [3]. AO-0003 had larger effects on the BJAB translatome than did AO-0002, which had a smaller effect at the same concentration (40 μM); however, AO-0002 caused higher upregulation of genes encoding class A rhodopsin-like GPCRs, mRNA processing proteins, and proteasome-related proteins than did AO-0003 (Figure 2, Table 2). Each of AO-0001, AO-0002, and AO-0003 exhibits antimeasles virus activity; however, AO-0001 and AO-0003 do not exhibit anti-respiratory syncytial virus (-RSV) activity [11]. It is possible that some host factors such as splicing factors or heterogeneous nuclear ribonucleoproteins (hnRNPs) listed in Table 2 might affect virus structure and/or replication cycle. Among the proteins encoded by these transcripts, heterogeneous nuclear ribonucleoprotein C (C1/C2), heterogeneous nuclear ribonucleoprotein K, human 55 kDa nuclear matrix protein/octamer-binding non-POU domain containing, and PTB 1 are each identified as an IRES-transacting factor [21]. Overall, our findings provided new insights into the mode of action of diarylheptanoids from A. officinarum with regard to anti-inflammatory, antitumor promotion, and antiviral effects.

5. Conclusions

This translatome analysis identified genes that were upregulated or downregulated by 2 h exposure to each of three diarylheptanoids from A. officinarum. Notably, genes related to mRNA processing and class A rhodopsin-like GPCRs were upregulated or downregulated by each of the three diarylheptanoids. Based on these findings, we propose that the biological effects of A. officinarum diarylheptanoids are mediated via control of expression of specific genes. Translatome analysis might be useful for advancing our understanding of molecular effects of complementary and alternative medicines.


5′ UTR:5′ untranslated region
BJAB:Human B-lymphoblastoma cell line
DMSO:Dimethyl sulfoxide
DNA:Deoxyribonucleic acids
GO:Gene ontology
GPCRs:G protein-coupled receptors
hnRNPs:Heterogeneous nuclear ribonucleoproteins
IL-18:Interleukin 18
IRES:Internal ribosome entry site
LSB:Low salt buffer
MAPK:Mitogen-activated protein kinases
mRNA:Messenger ribonucleic acid
RPMI medium:Roswell Park Memorial Institute medium
RSV:Respiratory syncytial virus
uORF:Upstream open reading frame.

Conflict of Interests

The authors declare no financial conflict of interests.


  1. K. Yasukawa, Y. Sun, S. Kitanaka, N. Tomizawa, M. Miura, and S. Motohashi, “Inhibitory effect of the rhizomes of Alpinia officinarum on TPA-induced inflammation and tumor promotion in two-stage carcinogenesis in mouse skin,” Journal of Natural Medicines, vol. 62, no. 3, pp. 374–378, 2008. View at: Publisher Site | Google Scholar
  2. H. Matsuda, S. Nakashima, Y. Oda, S. Nakamura, and M. Yoshikawa, “Melanogenesis inhibitors from the rhizomes of Alpinia officinarum in B16 melanoma cells,” Bioorganic and Medicinal Chemistry, vol. 17, no. 16, pp. 6048–6053, 2009. View at: Publisher Site | Google Scholar
  3. K. Tabata, U. Yamazaki, M. Okada et al., “Diarylheptanoids derived from alpinia officinarum induce apoptosis, S-phase arrest and differentiation in human neuroblastoma cells,” Anticancer Research, vol. 29, no. 12, pp. 4981–4988, 2009. View at: Google Scholar
  4. Y. Sun, K. Tabata, H. Matsubara, S. Kitanaka, T. Suzuki, and K. Yasukawa, “New cytotoxic diarylheptanoids from the rhizomes of Alpinia officinarum,” Planta Medica, vol. 74, no. 4, pp. 427–431, 2008. View at: Publisher Site | Google Scholar
  5. H. J. Lee, J. S. Kim, and J.-H. Ryu, “Suppression of inducible nitric oxide synthase expression by diarylheptanoids from Alpinia officinarum,” Planta Medica, vol. 72, no. 1, pp. 68–71, 2006. View at: Publisher Site | Google Scholar
  6. F. Kiuchi, M. Shibuya, and U. Sankawa, “Inhibitors of prostaglandin biosynthesis from Alpinia officinarum,” Chemical and Pharmaceutical Bulletin, vol. 30, no. 6, pp. 2279–2282, 1982. View at: Publisher Site | Google Scholar
  7. F. Kiuchi, S. Iwakami, M. Shibuya, F. Hanaoka, and U. Sankawa, “Inhibition of prostaglandin and leukotriene biosynthesis by gingerols and diarylheptanoids,” Chemical and Pharmaceutical Bulletin, vol. 40, no. 2, pp. 387–391, 1992. View at: Publisher Site | Google Scholar
  8. P. N. Yadav, Z. Liu, and M. M. Rafi, “A diarylheptanoid from lesser galangal (Alpinia officinarum) inhibits proinflammatory mediators via inhibition of mitogen-activated protein kinase, p44/42, and transcription factor nuclear factor-κB,” The Journal of Pharmacology and Experimental Therapeutics, vol. 305, no. 3, pp. 925–931, 2003. View at: Publisher Site | Google Scholar
  9. R. Sawamura, Y. Sun, K. Yasukawa, T. Shimizu, W. Watanabe, and M. Kurokawa, “Antiviral activities of diarylheptanoids against influenza virus in vitro,” Journal of Natural Medicines, vol. 64, no. 1, pp. 117–120, 2010. View at: Publisher Site | Google Scholar
  10. R. Sawamura, T. Shimizu, Y. Sun et al., “In vitro and in vivo anti-influenza virus activity of diarylheptanoids isolated from Alpinia officinarum,” Antiviral Chemistry and Chemotherapy, vol. 21, no. 1, pp. 33–41, 2010. View at: Publisher Site | Google Scholar
  11. K. Konno, R. Sawamura, Y. Sun et al., “Antiviral activities of diarylheptanoids isolated from Alpinia officinarum against respiratory syncytial virus, poliovirus, measles virus, and herpes simplex virus type 1 in vitro,” Natural Product Communications, vol. 6, no. 12, pp. 1881–1884, 2011. View at: Google Scholar
  12. K. Konno, M. Miura, M. Toriyama et al., “Antiviral activity of diarylheptanoid stereoisomers against respiratory syncytial virus in vitro and in vivo,” Journal of Natural Medicines, vol. 67, no. 4, pp. 773–781, 2013. View at: Publisher Site | Google Scholar
  13. Q. Zong, M. Schummer, L. Hood, and D. R. Morris, “Messenger RNA translation state: the second dimension of high-throughput expression screening,” Proceedings of the National Academy of Sciences of the United States of America, vol. 96, no. 19, pp. 10632–10636, 1999. View at: Publisher Site | Google Scholar
  14. O. Larsson, N. Sonenberg, and R. Nadon, “Identification of differential translation in genome wide studies,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 50, pp. 21487–21492, 2010. View at: Publisher Site | Google Scholar
  15. B. Schwanhüusser, D. Busse, N. Li et al., “Global quantification of mammalian gene expression control,” Nature, vol. 473, no. 7347, pp. 337–342, 2011. View at: Publisher Site | Google Scholar
  16. C. Vogel and E. M. Marcotte, “Insights into the regulation of protein abundance from proteomic and transcriptomic analyses,” Nature Reviews Genetics, vol. 13, no. 4, pp. 227–232, 2012. View at: Publisher Site | Google Scholar
  17. T. Tebaldi, A. Re, G. Viero et al., “Widespread uncoupling between transcriptome and translatome variations after a stimulus in mammalian cells,” BMC Genomics, vol. 13, no. 1, article 220, 2012. View at: Publisher Site | Google Scholar
  18. T. Kakegawa, N. Ohuchi, A. Hayakawa et al., “Identification of AUF1 as a rapamycin-responsive binding protein to the 5′-terminal oligopyrimidine element of mRNAs,” Archives of Biochemistry and Biophysics, vol. 465, no. 1, pp. 274–281, 2007. View at: Publisher Site | Google Scholar
  19. J. E. Kay, M. C. Smith, V. Frost, and G. Y. Morgan, “Hypersensitivity to rapamycin of BJAB B lymphoblastoid cells,” Immunology, vol. 87, no. 3, pp. 390–395, 1996. View at: Google Scholar
  20. S. Shishodia, “Molecular mechanisms of curcumin action: gene expression,” BioFactors, vol. 39, no. 1, pp. 37–55, 2013. View at: Publisher Site | Google Scholar
  21. C. Barbosa, I. Peixeiro, and L. Romão, “Gene expression regulation by upstream open reading frames and human disease,” PLoS Genetics, vol. 9, no. 8, Article ID e1003529, 2013. View at: Publisher Site | Google Scholar
  22. X. Pichon, L. A. Wilson, M. Stoneley et al., “RNA binding protein/RNA element interactions and the control of translation,” Current Protein and Peptide Science, vol. 13, no. 4, pp. 294–304, 2012. View at: Publisher Site | Google Scholar
  23. C. P. Chan, K. H. Kok, H. V. Tang, C. M. Wong, and D. Y. Jin, “Internal ribosome entry site-mediated translational regulation of ATF4 splice variant in mammalian unfolded protein response,” Biochimica et Biophysica Acta, vol. 1833, no. 10, pp. 2165–2175, 2013. View at: Publisher Site | Google Scholar
  24. K. W. Sherrill, M. P. Byrd, M. E. van Eden, and R. E. Lloyd, “BCL-2 translation is mediated via internal ribosome entry during cell stress,” The Journal of Biological Chemistry, vol. 279, no. 28, pp. 29066–29074, 2004. View at: Publisher Site | Google Scholar
  25. D. Warnakulasuriyarachchi, S. Cerquozzi, H. H. Cheung, and M. Holcík, “Translational induction of the inhibitor of apoptosis protein HIAP2 during endoplasmic reticulum stress attenuates cell death and is mediated via an inducible internal ribosome entry site element,” The Journal of Biological Chemistry, vol. 279, no. 17, pp. 17148–17157, 2004. View at: Publisher Site | Google Scholar
  26. K. A. Spriggs, L. C. Cobbold, S. H. Ridley et al., “The human insulin receptor mRNA contains a functional internal ribosome entry segment,” Nucleic Acids Research, vol. 37, no. 17, pp. 5881–5893, 2009. View at: Publisher Site | Google Scholar
  27. S. Vagner, M. C. Gensac, A. Maret et al., “Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes,” Molecular and Cellular Biology, vol. 15, no. 1, pp. 35–44, 1995. View at: Google Scholar
  28. K. J. D. Lang, A. Kappel, and G. J. Goodall, “Hypoxia-inducible factor-1α mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia,” Molecular Biology of the Cell, vol. 13, no. 5, pp. 1792–1801, 2002. View at: Publisher Site | Google Scholar
  29. T. Tebaldi, E. Dassi, G. Kostoska, G. Viero, and I. A. Quattrone, “tRanslatome: an R/Bioconductor package to portray translational control,” Bioinformatics, vol. 30, no. 2, pp. 289–291, 2014. View at: Google Scholar

Copyright © 2014 Tomohito Kakegawa et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

1110 Views | 866 Downloads | 8 Citations
 PDF  Download Citation  Citation
 Download other formatsMore
 Order printed copiesOrder

We are committed to sharing findings related to COVID-19 as quickly and safely as possible. Any author submitting a COVID-19 paper should notify us at help@hindawi.com to ensure their research is fast-tracked and made available on a preprint server as soon as possible. We will be providing unlimited waivers of publication charges for accepted articles related to COVID-19.